Menlo therapeutics inc. (MNLO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

0

-

-

-

0

-

-

-

-

-

-

-

-

Operating activities
Net loss

-

-

-

-

-

-51,445

-43,128

-38,454

-36,259

-29,076

0

0

0

Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

0

-

-

-

0

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

22

0

0

0

-

-

-

-

Depreciation and amortization

-

-

-

-

-

22

13

10

11

8

0

0

0

Changes in marketable securities and bank deposits, net

0

-

-

-

0

-

-

-

-

-

-

-

-

Changes in accrued liability for employee severance benefits, net of retirement fund profit

0

-

-

-

0

-

-

-

-

-

-

-

-

Amortization of premium on investment securities

-

-

-

-

-

774

558

341

104

-66

0

0

0

Stock-based compensation

7,510

6,701

4,634

4,156

3,766

3,638

2,799

2,393

1,958

1,452

0

0

0

Non-cash finance expenses(income), net

0

-

-

-

0

-

-

-

-

-

-

-

-

Changes in operating asset and liabilities, net of effects of businesses acquired:
Increase in trade receivables, prepaid and other assets

0

-

-

-

0

-

-

-

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

0

Change in operating assets and liabilities:
Accounts receivable

-

-

-

-

-

-786

0

0

0

-

-

-

0

Prepaid expenses and other current assets

-

-

-

-

-

-324

0

0

0

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-324

-1,116

324

1,536

1,790

0

0

0

increase in other non-current assets

0

-

-

-

0

-

-

-

85

-66

0

0

0

Increase (decrease) in accounts payable and accruals

0

-

-

-

0

-

-

-

-

-

-

-

-

Increase in inventory

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

825

-1,141

2,771

1,962

620

0

0

0

Accrued expenses and other current liabilities

-

-

-

-

-

2,719

3,475

-2,956

2,313

2,976

0

0

0

Deferred revenue

-

-

-

-

-

-8,531

0

0

0

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

0

0

0

Other non-current liabilities

-

-

-

-

-

-15

-6

60

5

-12

0

0

0

Net cash used in operating activities

-100,670

-65,101

-65,304

-61,099

-58,173

-52,733

-46,273

-46,619

-33,840

-28,222

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Investing activities
Purchase of fixed assets

-85

11

0

0

0

-

-

-

-

-

-

-

-

Investment in bank deposits

-

83,397

95,094

78,270

61,922

126,700

114,929

138,294

128,698

64,148

0

0

0

Cash acquired through merger

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale and maturity of marketable securities and bank deposits

0

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds from sales of investments

-

-

-

-

-

-

0

0

8,900

-

0

0

0

Proceeds from maturities of investments

-

-

-

-

-

87,864

86,429

61,795

51,282

43,085

0

0

0

Net cash provided by investing activities

99,615

41,374

24,229

47,131

19,729

-33,876

-23,530

-68,127

-68,543

-15,090

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Financing activities
Proceeds related to issuance of stock for stock-based compensation arrangements, net

160

36

0

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

0

0

0

-

-

-

0

Net cash provided by financing activities

5,118

4,994

5,123

5,439

540

125,913

0

0

0

-

-

-

0

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

0

-

-

-

0

-

-

-

-

-

-

-

-

EFFECT OF EXCHANGE RATE ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH

0

-

-

-

0

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

0

72,497

-

0

0

0

Noncash financing activities
Conversion of preferred stock to common stock

-

-

-

-

-

109,327

0

0

0

-

-

-

0